ANDREW LEVIN

Profile

First Name

: ANDREW

Middle Name

:

Last Name

: LEVIN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
IMMUNETICS, INC.
STEPHEN CHUBB, RICHARD GIBBS, RICHARD PINKOWITZ, LOIS SILVERMAN, JOHN YONKIN, HOURY YOUSSOUFIAN, RON ZWANZIGER
DIRECTOR
ARVINAS HOLDING COMPANY, LLC
SEAN CASSIDY, JOHN D. HOUSTON, JOHN G. HOUSTON, EDWARD KENNEDY, JR., MANUEL LITCHMAN, JAKOB LOVEN, BRAD MARGUS, BRADLEY MARGUS, BRIGGS MORRISON, KUSH PARMAR, LIAM RATCLIFFE, TIM SHANNON, TIMOTHY SHANNON, JONATHAN SODERSTROM, STEPHEN SQUINTO, IAN TAYLOR
DIRECTOR
SYNTHORX, INC.
DOUGLAS DOWNS, JAY LICHTER, TIGHE REARDON, FLOYD ROMESBERG, LAURA SHAWVER, PETER THOMPSON, COURT TURNER
EXECUTIVE OFFICER, DIRECTOR
CLEANBREAK, INC.
NICHOLAS MCGRATH, GERALD SEWACK
DIRECTOR
CLEAR CREEK BIO, INC.
BURT ADELMAN, VIKRAM S. KUMAR, DAVID SCADDEN
DIRECTOR
IMBRIA PHARMACEUTICALS, INC.
ZINA AFFAS BESSE, PIETER BOELHOUWER, PAVAN CHERUVU, CHARLES DUNN, DAVID-ALEXANDRE C. GROS, KEN HORNE, JAMES JANUZZI, KOMAL JOSHI, REBECCA LUSE, LUSE REBECCA, ALVIN SHIH
EXECUTIVE OFFICER, DIRECTOR
ELIEM THERAPEUTICS, INC.
SUSAN ALTSCHULLER, ROBERT AZELBY, AOIFE BRENNAN, JAMES BUCHER, ALEXANDER (BO) COMBO, KIMBERLEE DRAPKIN, JUDITH DUNN, DAVID-ALEXANDRE GROS, ERIN LAVELLE, VALERIE MORISSET, LEONE PATTERSON, LIAM RATCLIFFE, ADAM ROSENBERG, HARALD STOCK, SIMON TATE, STEPHEN THOMAS, JULIO VEGA, DOUGLAS WILLIAMS, PERRIN WILSON
EXECUTIVE OFFICER, DIRECTOR
ATHENEN THERAPEUTICS, INC.
AARON BERGENER, SARI EPSTEIN, SARAH REED, JOSHUA RESNICK, ADAM ROSENBERG, JAMES SCHNEIDER
EXECUTIVE OFFICER, DIRECTOR
ARCUATE THERAPEUTICS, INC.
AARON BERGENER, SARAH REED, JOSHUA RESNICK, JAMES SCHNEIDER
DIRECTOR
AEROVATE THERAPEUTICS, INC.
BENJAMIN DAKE, BENJAMIN T. DAKE, DAVID GRAYZEL, MAHA KATABI, JONATHAN LEFF, JOSHUA RESNICK, JAMES SCHNEIDER
DIRECTOR
SANTI THERAPEUTICS, INC.
NATHANIEL BROOKS HORWITZ, SHELLEY CHU, MILIND DESHPANDE, DAVID GRAYZEL, ANDREW HEDIN, LORENCE KIM, CHRISTOPHER O-DONNEL, CHRISTOPHER O-DONNELL, JIGAR RAYTHATHA, SIMON READ, JOSHUA RESNICK, PATRICK TROJER
DIRECTOR
CYTEK BIOSCIENCES, INC.
JACK BALL, FENG DENG, WENBIN JIANG, ALLEN POIRSON, MING YAN, JIECHENG ZHANG
DIRECTOR
METAGENOMI TECHNOLOGIES, LLC
SEBASTIAN BERNALES, WILLARD DERE, JUERGEN ECKHARDT, ANDREW FARQUHARSON, JAK KNOWLES, SANTHOSH PALANI, SANTOSH PALANI, RISA STACK, BRIAN THOMAS, BRIAN C. THOMAS
EXECUTIVE OFFICER, DIRECTOR
LUSARIS THERAPEUTICS, INC.
NEIL BUCKLEY, RAMIN FARZANEH-FAR, DANIEL GRAU, EDWARD MONAGHAN, CATHERINE RIESEN
DIRECTOR
SUPERLUMINAL MEDICINES, INC.
CONY D-CRUZ, DYLAN MORRIS, CRAIG RANDALL, CATHERINE RIESEN, DIAMANTIS XYLAS
DIRECTOR
NAVIGATOR MEDICINES, INC.
WILLIAM DALEY BONIFICIO, NAVEEN MANU DARYANI, WOUTER JOUSTRA, STEPHEN BASIL THOMAS
DIRECTOR
AKTIS ONCOLOGY, INC.
TODD FOLEY, KEN HERRMANN, HELEN S. KIM, OLEG NODELMAN, MATTHEW RODEN, SHULAMIT RON-BIGGER, LLOYD SEGAL
DIRECTOR
PAHR THERAPEUTICS, INC.
NEIL BUCKLEY, AMANDA CREEDON, KEN HORNE, ATSUSHI USAMI
DIRECTOR
LONESTAR MEDICINES, INC.
WILLIAM DALEY BONIFICIO, NAVEEN MANU DARYANI, GIANNA HOFFMAN-LUCA, STEPHEN BASIL THOMAS
DIRECTOR
SOLSTICE ONCOLOGY, INC.
DAVID FELTQUATE, JULIE GRANT, MORGAN HALLER, MAIKEN KESON-BROOKES, CAROLINE LOEW, EMILY MINKOW
DIRECTOR
SLATE MEDICINES, INC.
NEIL BUCKLEY, TIM LOHOFF, GREGORY FRANK OAKES, SARA PACHECO, CINDY XIONG
EXECUTIVE OFFICER, DIRECTOR
CLIMB BIO, INC.
SUSAN ALTSCHULLER, ROBERT AZELBY, AOIFE BRENNAN, JAMES BUCHER, ALEXANDER (BO) COMBO, KIMBERLEE DRAPKIN, JUDITH DUNN, DAVID-ALEXANDRE GROS, ERIN LAVELLE, VALERIE MORISSET, LEONE PATTERSON, LIAM RATCLIFFE, ADAM ROSENBERG, HARALD STOCK, SIMON TATE, STEPHEN THOMAS, JULIO VEGA, DOUGLAS WILLIAMS, PERRIN WILSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-29 
2026-03-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-17 
2026-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-20 
2026-02-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-01-12 
2025-12-16
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-03-10 
2025-08-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-08-14 
2025-07-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-02-27 
2025-04-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-03-10 
2024-10-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-20 
2024-09-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-23 
2024-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-21 
2024-07-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-06-27 
2024-07-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-06-27 
2023-08-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2022-12-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-13 
2021-05-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-05-21 
2021-03-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-15 
2020-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-23 
2020-11-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-16 
2020-07-31
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-19 
2020-07-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-22 
2020-07-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-22 
2020-01-08
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-30 
2019-10-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-10 
2019-10-23
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-04 
2019-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-30 
2019-10-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-27 
2019-10-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-19 
2019-02-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-04 
2018-07-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-02 
2018-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-20 
2018-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-12 
2018-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-29 
2017-06-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-31 
2016-07-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-14 
2015-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-16 
2014-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-26 
2012-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-07